SCHEMBL30796853

SCHEMBL30796853

CC(C)(C)OC(=O)N1CCN(c2ccnc(-c3cc(Cl)nnc3N)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.52
▸ SMARCA4 P51532 2/20 0.52
▸ PBRM1 Q86U86 2/20 0.52
▸ SUV39H2 Q9H5I1 7/20 0.44
▸ MAP4K4 O95819 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ PDK2 Q15119 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ CHRNA7 P36544 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ALK Q9UM73 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27461169 1.00 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1SUV39H2MAP4K4
SCHEMBL27461346 0.87 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1SUV39H2MAP4K4
SCHEMBL30796781 0.87 SMARCA2 (0.42) SMARCA2SMARCA4PBRM1SUV39H2MAP4K4
SCHEMBL30796629 0.86 SMARCA2 (0.72) SMARCA2SMARCA4PBRM1MAP4K4PDK2
SCHEMBL27461170 0.86 SMARCA2 (0.72) SMARCA2SMARCA4PBRM1MAP4K4PDK2
SCHEMBL25347440 0.84 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1MAP4K4MAPT
SCHEMBL30520162 0.84 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1MAP4K4MAPT
SCHEMBL27461283 0.82 SMARCA2 (0.57) SMARCA2SMARCA4PBRM1MAP4K4MAPT
SCHEMBL1432796 0.81 POLB (0.53) SUV39H2POLBMAPTPDK2MEN1
SCHEMBL30796928 0.80 SMARCA2 (0.54) SMARCA2SMARCA4PBRM1PDK2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback